Literature DB >> 2189055

Osteoporosis in men: diagnosis, pathophysiology, and prevention.

J A Jackson1, M Kleerekoper.   

Abstract

Osteoporosis in men is a significant problem in clinical medicine and in society in general. Systematic consideration of the differential diagnosis of osteopenia and osteoporosis in men is appropriate in every affected patient. Dynamic bone histomorphometry has diagnostic usefulness in some patients and has provided important pathogenetic implications by study of bone remodeling and turnover. Review of the multifactorial pathophysiology of age-related bone loss in men suggests that routine maintenance of adequate calcium and vitamin D intake, exercise, early recognition and treatment of testosterone deficiency, and modification of other osteoporotic risk factors may have prophylactic value. Future basic research on the cellular biology of bone in health and disease and clinical trials assessing the effects of long-term prophylactic and treatment regimens on bone mass and fracture occurrence will expand the understanding of osteoporosis in men.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189055     DOI: 10.1097/00005792-199005000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  18 in total

Review 1.  Bone loss in men.

Authors:  C Gennari; R Nuti
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

Review 2.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

Review 3.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

4.  Age-related changes in bone density among healthy Greek males.

Authors:  G E Krassas; F G Papadopoulou; D Doukidis; T H Konstantinidis; K Kalothetou
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

5.  Plasma levels of parathyroid hormone, vitamin D, calcitonin, and calcium in association with endurance exercise.

Authors:  T Klausen; L Breum; H A Sørensen; S Schifter; B Sonne
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

6.  Renal tubular disorders and arteriopathy of the lower limbs: risk factors for osteoporosis in men?

Authors:  M Laroche; L Moulinier; E Bon; A Cantagrel; B Mazieres
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

7.  Treatment considerations for vertebroplasty in men.

Authors:  Alan Hammond; Lee H Riley; Philippe Gailloud; David A Nussbaum; A Malhotra; Monica Watkins; Kieran J Murphy
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

Review 8.  Aetiologies of male osteoporosis: identification procedures.

Authors:  J P Mattei; D Arniaud; I Tonolli; H Roux
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

9.  Bone mineral content and anthropometric variables in men: a cross-sectional study in 324 normal subjects.

Authors:  H Rico; M Revilla; J Gonzalez-Riola; L F Villa; M Alvarez de Buergo
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

10.  Sex differences in the acquisition of total bone mineral mass peak assessed through dual-energy X-ray absorptiometry.

Authors:  H Rico; M Revilla; E R Hernandez; L F Villa; M Alvarez del Buergo
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.